logo

For the Inventor, By the Inventor

Indianapolis, IN, United States of America

Anton D Kiefer, Jr

This inventor holds 5 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1998-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anton D Kiefer, Jr. Retrieved from https://idiyas.com/inventor/anton-d-kiefer-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 43(Granted Patents)


Company Filing History:

goldMedal5 out of 4,514 
 
Eli Lilly and Company
 patents

Years Active: 1998-1999

Loading Chart...
5 patents (USPTO):Explore Patents
1. 5935992 - Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and (1999-08-10),
2. 5932739 - Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and (1999-08-03),
3. 5846995 - Substituted 1, 2, 3, 4-tetrahydro-2-dibenzofuranamines and (1998-12-08),
4. 5814653 - Pharmaceutical method using 6-substituted-1, 2, 3, (1998-09-29),
5. 5708187 - 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and (1998-01-13),

Title: **Inventor Spotlight: Anton D Kiefer, Jr**

Introduction

Anton D Kiefer, Jr is a renowned inventor based in Indianapolis, IN, USA. With a remarkable track record of five patents, Kiefer has made significant contributions to the field of pharmaceuticals, particularly focusing on the development of compounds that serve as 5-HT1F agonists.

Latest Patents

Kiefer's latest patents include innovations such as substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines, which provide valuable insights into drug development. The inventions are centered on substituted-2-amino-1,2,3,4-tetrahydrodibenzofurans and 2-aminocyclohepta-benzeno-furans, showcasing their utility as effective 5-HT1F agonists.

Career Highlights

Kiefer is associated with Eli Lilly and Company, a leading global healthcare firm recognized for its innovative solutions in medications and therapeutic advancements. His work at the company reflects a robust commitment to improving health outcomes through groundbreaking research and development.

Collaborations

Throughout his career, Kiefer has collaborated with esteemed coworkers such as Michael E Flaugh and Clint Duane Walker. These partnerships have fostered an environment of innovation and have contributed to the successful development of several patents.

Conclusion

Anton D Kiefer, Jr’s contributions to the pharmaceutical sector underline the importance of innovation in healthcare. With his remarkable portfolio of patents and collaborations, Kiefer continues to inspire future inventors in the field of drug discovery and development. His work exemplifies the impact that dedicated inventors can have on scientific advancements and public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…